Feedback / Questions
Krazati (adagrasib) - Mirati
KRAS specific TCR-T Cell Therapy - Shanghai Bintie Biotech
https://ascopost.com/issues/february-10-2023/krystal-1-confirms-activity-of-adagrasib-in-kras-g12c-mutated-metastatic-colorectal-cancer-and-highlights-need-for-randomized-controlled-trials/
Feb 10, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious